Drug
Carbogen
Carbogen is a pharmaceutical drug with 4 clinical trials. Historical success rate of 25.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
25.0%
Based on 1 completed trials
Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(75%)
Phase Distribution
Ph phase_3
2
50%
Ph phase_2
1
25%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
25.0%
1 of 4 finished
Non-Completion Rate
75.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(3)
Detailed Status
Terminated3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 32 (50.0%)
Trials by Status
completed125%
terminated375%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_3
Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)
NCT04839224
terminatedphase_2
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
NCT01370044
terminatedphase_1
Imaging and Biomarkers of Hypoxia in Solid Tumors
NCT01123005
completedphase_3
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
NCT00033436
Clinical Trials (4)
Showing 4 of 4 trials
NCT04839224Phase 3
Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)
NCT01370044Phase 2
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
NCT01123005Phase 1
Imaging and Biomarkers of Hypoxia in Solid Tumors
NCT00033436Phase 3
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4